Drug class in one race
IL-5 drugs for Chronic Obstructive Pulmonary Disease
2 tracked IL-5 drugs in the Chronic Obstructive Pulmonary Disease race. The class explanation lives on the IL-5 page; the full indication pipeline across every mechanism is on the Chronic Obstructive Pulmonary Disease page.
1 approved / phase 41 Phase 3
Head-to-head evidence: Depemokimab vs Mepolizumab